SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

neuroimaging

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diagnostics-neuroimaging
Related Entities
diagnostics-neuroimaging
Metadata
slugdiagnostics-neuroimaging
entity_typegeneral
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (563)
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
mentions🧪Netrin-1 Gradient Restoration65%
mentions🧪Smartphone-Detected Motor Variability Correction65%
mentions🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio65%
mentions🧪Mitochondrial-Lysosomal Contact Site Engineering65%
mentions🧪Circadian-Synchronized Proteostasis Enhancement65%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration65%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement65%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer65%
mentions🧪Mitochondrial SPM Synthesis Platform Engineering65%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon65%
mentions🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective65%
mentions🧪VCP-Mediated Autophagy Enhancement65%
mentions🧪Arginine Methylation Enhancement Therapy65%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption65%
mentions🧪Mitochondrial RNA Granule Rescue Pathway65%
mentions🧪Multi-Modal Stress Response Harmonization65%
mentions🧪Complement C1q Mimetic Decoy Therapy65%
mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc65%
mentions🧪CYP46A1 Overexpression Gene Therapy65%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m65%
mentions🧪Retinal Vascular Microcirculation Rescue65%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition65%
mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho65%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation65%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi65%
mentions🧪Noradrenergic-Tau Propagation Blockade65%
mentions🧪Adenosine-Astrocyte Metabolic Reset65%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones65%
mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists65%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations65%
mentions🧪Quantum Coherence Disruption in Cellular Communication65%
mentions🧪The Glial Ketone Metabolic Shunt Hypothesis65%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation65%
mentions🧪LRP1-Dependent Tau Uptake Disruption65%
mentions🧪Cryptic Exon Silencing Restoration65%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy65%
mentions🧪Extracellular Vesicle Biogenesis Modulation65%
mentions🧪APOE-Mediated Synaptic Lipid Raft Stabilization65%
mentions🧪Complement C1q Subtype Switching65%
mentions🧪Microglial Purinergic Reprogramming65%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification65%
mentions🧪Autophagosome Maturation Checkpoint Control65%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener65%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal65%
mentions🧪Prefrontal sensory gating circuit restoration via PV interne65%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement65%
mentions🧪Sphingolipid Metabolism Reprogramming65%
mentions🧪PARP1 Inhibition Therapy65%
mentions🧪Low Complexity Domain Cross-Linking Inhibition65%
mentions🧪Ocular Immune Privilege Extension65%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy65%
mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation65%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu65%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation65%
mentions🧪Perforant Path Presynaptic Terminal Protection Strategy65%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset65%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading65%
mentions🧪Piezoelectric Nanochannel BBB Disruption65%
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis65%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation65%
mentions🧪Axonal RNA Transport Reconstitution65%
mentions🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci65%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In65%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification65%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna65%
mentions🧪Orexin-Microglia Modulation Therapy65%
mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation65%
mentions🧪Lysosomal Membrane Repair Enhancement65%
mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement65%
mentions🧪Lysosomal Calcium Channel Modulation Therapy65%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue65%
mentions🧪Mitochondrial Transfer Pathway Enhancement65%
mentions🧪Stress Granule Phase Separation Modulators65%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr65%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction65%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation65%
mentions🧪Flotillin-1 Stabilization Compounds65%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization65%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy65%
mentions🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A65%
mentions🧪Complement-Mediated Synaptic Pruning Dysregulation65%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling65%
mentions🧪HDAC3-Selective Inhibition for Clock Reset65%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering65%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati65%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th65%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation65%
mentions🧪Digital Twin-Guided Metabolic Reprogramming65%
mentions🧪Lysosomal Positioning Dynamics Modulation65%
mentions🧪Lysosomal Enzyme Trafficking Correction65%
mentions🧪Circadian Clock-Autophagy Synchronization65%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides65%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri65%
mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai65%
mentions🧪R-Loop Resolution Enhancement Therapy65%
mentions🧪Senescence-Activated NAD+ Depletion Rescue65%
mentions🧪Competitive APOE4 Domain Stabilization Peptides65%
mentions🧪Epigenetic Memory Erasure via TET2 Activation65%
mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol65%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy65%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)65%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors65%
mentions🧪Ephrin-B2/EphB4 Axis Manipulation65%
mentions🧪Microbial Inflammasome Priming Prevention65%
mentions🧪Phase-Separated Organelle Targeting65%
mentions🧪Nucleolar Stress Response Normalization65%
mentions🧪Vagal Afferent Microbial Signal Modulation65%
mentions🧪Cross-Seeding Prevention Strategy65%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch65%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming65%
mentions🧪Trans-Synaptic Adhesion Molecule Modulation65%
mentions🧪RNA Granule Nucleation Site Modulation65%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation65%
mentions🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation65%
mentions🧫DDT/DDE exposure and brain cortical thickness analysis60%
mentions🧫KEEPS Continuation: Long-term effects of menopausal hormone 60%
mentions🧫Brain Connectivity-Targeted tACS Trial in Early AD60%
mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%
mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%
mentions🧫4R-Tau Targeting Therapies for PSP and CBS60%
mentions🧫AAV-LRRK2 IND-Enabling Study Design60%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi60%
mentions🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
mentions🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
mentions🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
mentions🧫Alpha-Synuclein Seed Amplification Assay Validation60%
mentions🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
mentions🧫Metabolic Pathway-Targeted Therapy in ALS60%
mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti60%
mentions🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?60%
mentions🧫Animal Model Comparison for Neurodegenerative Disease Therap60%
mentions🧫Anti-Tau Immunotherapy Dosing Optimization60%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
mentions🧫Antiviral Therapy Trial for Parkinson's Disease60%
mentions🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
mentions🧫Experiment: Autoimmune Hypothesis Testing in AD60%
mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration60%
mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
mentions🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#60%
mentions🧫Blood-Based Biomarker Panel for Early AD Detection60%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
mentions🧫tACS Connectivity Trial in Early Alzheimer's60%
mentions🧫Brainstem Circuit Modulation for PSP60%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
mentions🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
mentions🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
mentions🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr60%
mentions🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M60%
mentions🧫Combination Therapy Sequencing in Parkinson's Disease60%
mentions🧫CRISPR Gene Correction Approaches for CBS/PSP60%
mentions🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera60%
mentions🧫DLB Cognitive Fluctuation Mechanism Experiment60%
mentions🧫Genetic Risk Modifiers in DLB Phenotype60%
mentions🧫Tau Co-Pathology in DLB Clinical Heterogeneity60%
mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras60%
mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera60%
mentions🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
mentions🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%
mentions🧫Epigenetic Dysregulation in Huntington's Disease — Ther60%
mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa60%
mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%
mentions🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
mentions🧫Experiment Index60%
mentions🧫Ferroptosis Validation in Parkinson's Disease60%
mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M60%
mentions🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud60%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation60%
mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
mentions🧫Gap Junction Dysfunction Validation in Parkinson's Dise60%
mentions🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
mentions🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin60%
mentions🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
mentions🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
mentions🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment60%
mentions🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design60%
mentions🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre60%
mentions🧫Cytochrome Therapeutics60%
mentions🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
mentions🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
mentions🧫Macroautophagy Dysfunction in PD - Experiment Design60%
mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
mentions🧫Validation: Membrane-Nucleation in iPSC Neurons60%
mentions🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise60%
mentions🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
mentions🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 60%
mentions🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
mentions🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech60%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr60%
mentions🧫Microglial Contributions to Huntington's Disease Pathog60%
mentions🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis60%
mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress60%
mentions🧫MLCS Quantification in Parkinson's Disease60%
mentions🧫Experiment: Multi-Ethnic PD GWAS60%
mentions🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
mentions🧫N-of-1 Clinical Trial Design for CBS/PSP60%
mentions🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease60%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
mentions🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
mentions🧫Normal Aging to Alzheimer's Disease Transition Trigger 60%
mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%
mentions🧫NPH Glymphatic System Interaction Experiment60%
mentions🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
mentions🧫Parkinson's Disease Subtype Classification — Precision 60%
mentions🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
mentions🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
mentions🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G60%
mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
mentions🧫Prion Strain Diversity and Selective Vulnerability in CJD60%
mentions🧫Prodromal Parkinson's Disease Biomarker Development — E60%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development60%
mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
mentions🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
mentions🧫PSP and CBS Biomarker Validation Study60%
mentions🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
mentions🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel60%
mentions🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%
mentions🧫Experiment Scoring Methodology60%
mentions🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec60%
mentions🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#60%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and60%
mentions🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
mentions🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati60%
mentions🧫Sleep Disruption and Alzheimer's Disease — mechanism an60%
mentions🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
mentions🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
mentions🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
mentions🧫Tau Pathology Initiation Zone Identification60%
mentions🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo60%
mentions🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro60%
mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation60%
mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%
mentions🧫TDP-43 PET Ligand Development for FTD and ALS60%
mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an60%
mentions🧫Tau ASO Therapy60%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia60%
mentions🧫Vascular Contribution to Alzheimer's Disease — Beyond A60%
mentions🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol60%
mentions🧫Viral Infections and Alzheimer's Disease — causal mecha60%
mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
mentions🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 60%
related🧪Smartphone-Detected Motor Variability Correction58%
related🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio58%
related🧪Mitochondrial-Lysosomal Contact Site Engineering58%
related🧪Circadian-Synchronized Proteostasis Enhancement58%
related🧪HSP90-Tau Disaggregation Complex Enhancement58%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer58%
related🧪Mitochondrial SPM Synthesis Platform Engineering58%
related🧪CX43 hemichannel engineering enables size-selective mitochon58%
related🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective58%
related🧪VCP-Mediated Autophagy Enhancement58%
related🧪Arginine Methylation Enhancement Therapy58%
related🧪SASP-Mediated Cholinergic Synapse Disruption58%
related🧪Mitochondrial RNA Granule Rescue Pathway58%
related🧪Multi-Modal Stress Response Harmonization58%
related🧪Complement C1q Mimetic Decoy Therapy58%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc58%
related🧪CYP46A1 Overexpression Gene Therapy58%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m58%
related🧪Retinal Vascular Microcirculation Rescue58%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition58%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho58%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation58%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi58%
related🧪Noradrenergic-Tau Propagation Blockade58%
related🧪Adenosine-Astrocyte Metabolic Reset58%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones58%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists58%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations58%
related🧪Quantum Coherence Disruption in Cellular Communication58%
related🧪The Glial Ketone Metabolic Shunt Hypothesis58%
related🧪LRP1-Dependent Tau Uptake Disruption58%
related🧪Cryptic Exon Silencing Restoration58%
related🧪SIRT6-NAD+ Axis Enhancement Therapy58%
related🧪Extracellular Vesicle Biogenesis Modulation58%
related🧪APOE-Mediated Synaptic Lipid Raft Stabilization58%
related🧪Complement C1q Subtype Switching58%
related🧪Microglial Purinergic Reprogramming58%
related🧪Heat Shock Protein 70 Disaggregase Amplification58%
related🧪Autophagosome Maturation Checkpoint Control58%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener58%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal58%
related🧪Prefrontal sensory gating circuit restoration via PV interne58%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement58%
related🧪Sphingolipid Metabolism Reprogramming58%
related🧪PARP1 Inhibition Therapy58%
related🧪Low Complexity Domain Cross-Linking Inhibition58%
related🧪Ocular Immune Privilege Extension58%
related🧪Hypocretin-Neurogenesis Coupling Therapy58%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation58%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu58%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation58%
related🧪Perforant Path Presynaptic Terminal Protection Strategy58%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset58%
related🧪Senescence-Induced Lipid Peroxidation Spreading58%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis58%
related🧪SASP-Driven Aquaporin-4 Dysregulation58%
related🧪Axonal RNA Transport Reconstitution58%
related🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci58%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In58%
related🧪Circadian-Gated Maresin Biosynthesis Amplification58%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna58%
related🧪Orexin-Microglia Modulation Therapy58%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation58%
related🧪Lysosomal Membrane Repair Enhancement58%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement58%
related🧪Lysosomal Calcium Channel Modulation Therapy58%
related🧪Mitochondrial Transfer Pathway Enhancement58%
related🧪Stress Granule Phase Separation Modulators58%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr58%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction58%
related🧪Pharmacological Enhancement of APOE4 Glycosylation58%
related🧪Flotillin-1 Stabilization Compounds58%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization58%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy58%
related🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A58%
related🧪Complement-Mediated Synaptic Pruning Dysregulation58%
related🧪HDAC3-Selective Inhibition for Clock Reset58%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering58%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati58%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th58%
related🧪Digital Twin-Guided Metabolic Reprogramming58%
related🧪Lysosomal Positioning Dynamics Modulation58%
related🧪Lysosomal Enzyme Trafficking Correction58%
related🧪Circadian Clock-Autophagy Synchronization58%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides58%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri58%
related🧪R-Loop Resolution Enhancement Therapy58%
related🧪Senescence-Activated NAD+ Depletion Rescue58%
related🧪Competitive APOE4 Domain Stabilization Peptides58%
related🧪Epigenetic Memory Erasure via TET2 Activation58%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol58%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy58%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)58%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors58%
related🧪Ephrin-B2/EphB4 Axis Manipulation58%
related🧪Microbial Inflammasome Priming Prevention58%
related🧪Phase-Separated Organelle Targeting58%
related🧪Nucleolar Stress Response Normalization58%
related🧪Vagal Afferent Microbial Signal Modulation58%
related🧪Cross-Seeding Prevention Strategy58%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch58%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming58%
related🧪RNA Granule Nucleation Site Modulation58%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation58%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation58%
related🧫DDT/DDE exposure and brain cortical thickness analysis54%
related🧫KEEPS Continuation: Long-term effects of menopausal hormone 54%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%
related🧫4R-Tau Targeting Therapies for PSP and CBS54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti54%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?54%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap54%
related🧫Anti-Tau Immunotherapy Dosing Optimization54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Experiment: Autoimmune Hypothesis Testing in AD54%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#54%
related🧫Blood-Based Biomarker Panel for Early AD Detection54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫tACS Connectivity Trial in Early Alzheimer's54%
related🧫Brainstem Circuit Modulation for PSP54%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr54%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera54%
related🧫DLB Cognitive Fluctuation Mechanism Experiment54%
related🧫Genetic Risk Modifiers in DLB Phenotype54%
related🧫Tau Co-Pathology in DLB Clinical Heterogeneity54%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P54%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa54%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Experiment Index54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M54%
related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud54%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🧫Gap Junction Dysfunction Validation in Parkinson's Dise54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment54%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design54%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre54%
related🧫Cytochrome Therapeutics54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech54%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr54%
related🧫Microglial Contributions to Huntington's Disease Pathog54%
related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis54%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 54%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%
related🧫NPH Glymphatic System Interaction Experiment54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Prion Strain Diversity and Selective Vulnerability in CJD54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel54%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease54%
related🧫Experiment Scoring Methodology54%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec54%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#54%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati54%
related🧫Sleep Disruption and Alzheimer's Disease — mechanism an54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫Tau Pathology Initiation Zone Identification54%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo54%
related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro54%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation54%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an54%
related🧫Tau ASO Therapy54%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia54%
related🧫Vascular Contribution to Alzheimer's Disease — Beyond A54%
related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol54%
related🧫Viral Infections and Alzheimer's Disease — causal mecha54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 54%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🧪Netrin-1 Gradient Restoration40%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
related🧪Piezoelectric Nanochannel BBB Disruption40%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%
related🧪Trans-Synaptic Adhesion Molecule Modulation40%
related🔬What are the mechanisms underlying selective vulnerability o39%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp39%
related🔬What are the mechanisms underlying tdp-43 phase separation t39%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub